Craig-Schapiro et al. (2010) described higher YKL-40 CSF levels in AD patients compared to controls, and progressive supranucleal palsy, however the exact results are not available, and this study was not included in the quantitative analysis of the present study [30]. Here, CHI3L1 is linked to Alzheimer disease.